The Irs2−/− mice have been shown to have increased levels of the cyclin-dependent kinase inhibitor p27kip1 in β-cells, and the loss of β-cell mass and diabetes was corrected when these mice were placed on a p27kip1 null background [40]. This evidence concerns the gene CDKN3 and diabetes mellitus.